Functionalized graphene oxide serves as a novel vaccine nano-adjuvant for robust stimulation of cellular immunity

Nanoscale
Ligeng XuRui Peng

Abstract

Benefiting from their unique physicochemical properties, graphene derivatives have attracted great attention in biomedicine. In this study, we carefully engineered graphene oxide (GO) as a vaccine adjuvant for immunotherapy using urease B (Ure B) as the model antigen. Ure B is a specific antigen for Helicobacter pylori, which is a class I carcinogen for gastric cancer. Polyethylene glycol (PEG) and various types of polyethylenimine (PEI) were used as coating polymers. Compared with single-polymer modified GOs (GO-PEG and GO-PEI), certain dual-polymer modified GOs (GO-PEG-PEI) can act as a positive modulator to promote the maturation of dendritic cells (DCs) and enhance their cytokine secretion through the activation of multiple toll-like receptor (TLR) pathways while showing low toxicity. Moreover, this GO-PEG-PEI can serve as an antigen carrier to effectively shuttle antigens into DCs. These two advantages enable GO-PEG-PEI to serve as a novel vaccine adjuvant. In the subsequent in vivo experiments, compared with free Ure B and clinically used aluminum-adjuvant-based vaccine (Alum-Ure B), GO-PEG-PEI-Ure B induces stronger cellular immunity via intradermal administration, suggesting promising applications in cancer immunotherap...Continue Reading

References

Aug 1, 1992·AIDS Research and Human Retroviruses·R Edelman
Apr 1, 1998·Nature·J Banchereau, R M Steinman
Jun 14, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antoni RibasJames S Economou
Oct 14, 2004·Immunology and Cell Biology·Nikolai Petrovsky, Julio César Aguilar
Jan 6, 2005·Journal of the American Chemical Society·Alberto BiancoCharalambos D Partidos
Jun 15, 2005·ILAR Journal·Michael K Schunk, G Eileen Macallum
Jan 13, 2006·International Journal of Cancer. Journal International Du Cancer·Donald Maxwell Parkin
Jul 21, 2006·Nature·Sasha StankovichRodney S Ruoff
Mar 3, 2007·Nature Materials·A K Geim, K S Novoselov
Mar 6, 2007·Immunologic Research·Alicia R Mathers, Adriana T Larregina
Jun 19, 2007·Nature Immunology·Eicke LatzDouglas T Golenbock
Sep 18, 2007·Nature Biotechnology·Sai T ReddyJeffrey A Hubbell
Sep 12, 2008·Helicobacter·Tamara VorobjovaTsutomu Chiba
Nov 26, 2008·Nature Immunology·Troy D QuerecBali Pulendran
Nov 20, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Igor M Belyakov, Jeffrey D Ahlers
Aug 12, 2010·Journal of the American Chemical Society·Lena Ai Ling TangKian Ping Loh
Aug 24, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Deepa MohananPål Johansen
Nov 26, 2010·Helicobacter·Toni AebischerLeif P Andersen
Nov 26, 2010·Nature Chemistry·Kian Ping LohManish Chhowalla
Dec 7, 2010·Toxicology Letters·Yanli ChangHaifang Wang
Jan 29, 2011·Nanoscale·Liangzhu FengZhuang Liu
Dec 7, 2011·Chemical Society Reviews·Yuxin LiuPeng Chen
Jun 27, 2012·Clinica Chimica Acta; International Journal of Clinical Chemistry·Joshua J Augustine, Donald E Hricik
Aug 28, 2012·Nature Biotechnology·Frank WegmannQuentin J Sattentau
Oct 13, 2012·Chemical Society Reviews·Kai YangZhuang Liu

❮ Previous
Next ❯

Citations

Sep 21, 2016·Journal of Drug Targeting·Nazanin RahmanianYadollah Omidi
Mar 25, 2017·Nanomaterials·Ting YanXiao-Dong Gao
Feb 12, 2017·Materials Science & Engineering. C, Materials for Biological Applications·Huijie ZhangXiao-Dong Gao
Jul 1, 2017·Frontiers in Immunology·Sourav P MukherjeeBengt Fadeel
Jan 6, 2019·The Journal of Pharmacology and Experimental Therapeutics·Hyunjoon KimJayanth Panyam
Oct 1, 2020·Biomaterials Science·Tongyi ShangBin Yang
Apr 8, 2020·Nanoscale Horizons : the Home for Rapid Reports of Exceptional Significance in Nanoscience and Nanotechnolgy·V PalmieriM Papi
Aug 18, 2016·Helicobacter·Dominique VelinMarkus Gerhard
Mar 1, 2019·Advanced Biosystems·Junyu CaiYaping Li
Jun 30, 2019·Advanced Materials·C Wyatt ShieldsSamir Mitragotri
Feb 6, 2020·Angewandte Chemie·Shuang LiuHuiyu Liu
Nov 23, 2020·Bulletin of Experimental Biology and Medicine·S A ZamorinaM B Raev
Oct 15, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Qiutong JinQian Chen
May 5, 2021·Proceedings of the National Academy of Sciences of the United States of America·Chunhong DongBao-Zhong Wang
Oct 9, 2017·ACS Biomaterials Science & Engineering·Zhong GuoWei Xue
Sep 12, 2020·Chemical Reviews·Wen-Hao Li, Yan-Mei Li
Feb 11, 2019·ACS Biomaterials Science & Engineering·Hongyuan YuanZonghua Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.